Search

Search Constraints

You searched for: Author/Creator Grimaudo, Stefania

Search Results

1. A cholestatic pattern predicts major liver‐related outcomes in patients with non‐alcoholic fatty liver disease. (12th March 2022)

2. A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease. Issue 5 (11th February 2022)

3. Aminopyrine breath test predicts liver‐related events and death in HCV‐related cirrhosis on SVR after DAA therapy. (25th September 2019)

5. Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis. (4th August 2020)

6. Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease. Issue 6 (6th November 2017)

7. NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease. (29th July 2021)

8. PCSK9 rs11591147 R46L loss‐of‐function variant protects against liver damage in individuals with NAFLD. (2nd November 2020)

10. Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease. Issue 6 (25th April 2018)